What is the incidence of methotrexate or leflunomide discontinuation related to cytopenia, liver enzyme elevation or kidney function decline?

Georgina Nakafero, Matthew J Grainge, Tim Card, Christian D Mallen, Weiya Zhang, Michael Doherty, Maarten W Taal, Guruprasad P Aithal, Abhishek Abhishek

Open source

DOI: 10.1093/rheumatology/keab254
Published: 2021-03-16
Container: Rheumatology
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/rheumatology/keab254,
  title = {What is the incidence of methotrexate or leflunomide discontinuation related to cytopenia, liver enzyme elevation or kidney function decline?},
  author = {Georgina Nakafero and Matthew J Grainge and Tim Card and Christian D Mallen and Weiya Zhang and Michael Doherty and Maarten W Taal and Guruprasad P Aithal and Abhishek Abhishek},
  year = {2021},
  journal = {Rheumatology},
  doi = {10.1093/rheumatology/keab254},
  url = {https://doi.org/10.1093/rheumatology/keab254}
}

RIS

TY  - JOUR
TI  - What is the incidence of methotrexate or leflunomide discontinuation related to cytopenia, liver enzyme elevation or kidney function decline?
AU  - Georgina Nakafero
AU  - Matthew J Grainge
AU  - Tim Card
AU  - Christian D Mallen
AU  - Weiya Zhang
AU  - Michael Doherty
AU  - Maarten W Taal
AU  - Guruprasad P Aithal
AU  - Abhishek Abhishek
PY  - 2021
JO  - Rheumatology
DO  - 10.1093/rheumatology/keab254
UR  - https://doi.org/10.1093/rheumatology/keab254
ER  -

APA

Nakafero, G., Grainge, M. J., Card, T., Mallen, C. D., Zhang, W., Doherty, M., Taal, M. W., Aithal, G. P., & Abhishek, A. (2021). What is the incidence of methotrexate or leflunomide discontinuation related to cytopenia, liver enzyme elevation or kidney function decline?. Rheumatology. https://doi.org/10.1093/rheumatology/keab254

Source records

crossref · retrieved 2026-11-06T22:27:16.607Z